Get 20% lifetime commission for referring investors to digrin.com
here.
Suven Pharmaceuticals Ltd - stock earnings
SUVENPHAR.NS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 467.5 million INR | 2.2 billion INR |
| 2023Q3 | 795.6 million INR | 2.3 billion INR |
| 2023Q2 | 1.2 billion INR | 3.5 billion INR |
| 2023Q1 | 1.2 billion INR | 3.7 billion INR |
| 2022Q4 | 1.1 billion INR | 3.5 billion INR |
| 2022Q3 | 720.6 million INR | 2.8 billion INR |
| 2022Q2 | 1.1 billion INR | 3.4 billion INR |
| 2022Q1 | 1.2 billion INR | 3.4 billion INR |
| 2021Q4 | 1.6 billion INR | 3.9 billion INR |
| 2021Q3 | 969.8 million INR | 3.0 billion INR |
| 2021Q2 | 1.1 billion INR | 2.6 billion INR |
| 2021Q1 | 831.2 million INR | 2.3 billion INR |
| 2020Q4 | 1.1 billion INR | 2.7 billion INR |
| 2020Q3 | 740.8 million INR | 2.4 billion INR |
| 2020Q2 | 915.2 million INR | 2.4 billion INR |
| 2020Q1 | 741.8 million INR | 1.6 billion INR |
| 2019Q4 | 579.1 million INR | 1.8 billion INR |
| 2019Q3 | 930.0 million INR | 2.7 billion INR |
| 2019Q2 | 919.0 million INR | 2.0 billion INR |
| 2019Q1 | 748.2 million INR | 2.4 billion INR |
| 2018Q4 | 344.5 million INR | 1.3 billion INR |
SUVENPHAR.NS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 4.1 billion INR | 13.4 billion INR |
| 2022 | 4.5 billion INR | 12.9 billion INR |
| 2021 | 3.6 billion INR | 9.8 billion INR |
| 2020 | 3.2 billion INR | 8.1 billion INR |
| 2019 | 1.1 billion INR | 3.7 billion INR |
SUVENPHAR.NS
Price: ₹644.15
52 week price:
Earnings Per Share: 14.56 INR
P/E Ratio: 39.24
Exchange: NSI
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 165.2 billion
Average Dividend Frequency: 3